(Q44036566)

29 November 2017

title

Characterisation of atovaquone resistance in Leishmania infantum promastigotes (English)

1 reference

29 November 2017

1 reference

Cauchetier E

1

1 reference

29 November 2017

Loiseau PM

2

1 reference

29 November 2017

Lehman J

3

1 reference

29 November 2017

Rivollet D

4

1 reference

29 November 2017

Fleury J

5

1 reference

29 November 2017

Astier A

6

1 reference

29 November 2017

Deniau M

7

1 reference

29 November 2017

Paul M

8

1 reference

29 November 2017

publication date

1 July 2002

1 reference

International Journal for Parasitology

29 November 2017

published in

1 reference

29 November 2017

volume

32

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

1043-1051

1 reference

Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Sterol, Structure and Membrane Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Plasmodium and Leishmania: the role of mdr genes in mediating drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

The activity of hydroxynaphthoquinones against Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Function, evolution and structure of multidrug resistance protein (MRP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

The function of sterols in membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Paromomycin resistance in Leishmania tropica: lack of correlation with mutation in the small subunit ribosomal RNA gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Stable amplified DNA in drug-resistant Leishmania exists as extrachromosomal circles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Lipid membrane structure and interactions in dimethyl sulfoxide/water mixtures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

In vitro activity of atovaquone against Leishmania chagasi promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Development and characterization of paromomycin-resistant Leishmania donovani promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Mechanisms of drug resistance in Leishmania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Mechanism of action of amphotericin B on Leishmania donovani promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Increased P-Type ATPase Activity in Leishmania tropica Resistant to Methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

The physiological function of drug-transporting P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900065-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7519(02)00065-6

1 reference

29 November 2017

1 reference